1. Yang W, Deng B, Huang Y, Liu J, Huang Z, Chang Z, et al. Two heterozygous progranulin mutations in progressive supranuclear palsy. Brain. 2021;144(3):e27.
2. Xie F, Gao X, Yang W, Chang Z, Yang X, Wei X, et al. Advances in the research of risk factors and prodromal biomarkers of Parkinson’s disease. ACS Chem Neurosci. 2019;10(2):973–90.
3. Yang W, Chang Z, Que R, Weng G, Deng B, Wang T, et al. Contra-directional expression of plasma superoxide dismutase with lipoprotein chcolesterol and high-sensitivity c-reactive protein as important markers of Parkinson’s disease severity. Front Aging Neurosci. 2020;12:53.
4. Lin Y, Fu Y, Zeng YF, Hu JP, Lin XZ, Cai NQ, et al. Six visual rating scales as a biomarker for monitoring atrophied brain volume in Parkinson’s disease. Aging Dis. 2020;11(5):1082–90.
5. Jia Y, Wang N, Zhang Y, Xue D, Lou H, Liu X. Alteration in the function and expression of SLC and ABC transporters in the neurovascular unit in Alzheimer’s disease and the clinical significance. Aging Dis. 2020;11(2):390–404.